For the Inventor, By the Inventor

Enter inventor name

Bryn Mawr, PA, United States of America

Eduardo J Martinez

USPTO Granted Patents = 21 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 32(Granted Patents)

Company Filing History:

Haro Pharmaceuticals Inc.

4. 3 out of 295

The Royal Institution for the Advancement of Learning / Mcgill University

5. 3 out of 183

Universitéde Montreal

Euclises Pharmaceuticals, Inc.

7. 2 out of 4,550

California Institute of Technology

Holoclara, Inc.

Tansna Therapeutics, Inc.

Sea Pharmaceuticals LLC

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Loading Chart...

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473323 - Ascaroside derivatives and methods of use (2025-11-18),

2. 12258303 - Metal salts and uses thereof (2025-03-25),

3. 11878956 - Metal salts and uses thereof (2024-01-23),

4. 11845770 - Ascaroside derivatives and methods of use (2023-12-19),

5. 11685726 - Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereof (2023-06-27),

6. 11629118 - Formulations with improved stability (2023-04-18),

7. 11459292 - Metal salts and uses thereof (2022-10-04),

8. 11174220 - Metal salts and uses thereof (2021-11-16),

9. 10954194 - 18-20 member bi-polycyclic compounds (2021-03-23),

10. 10752591 - 18-20 member bi-polycyclic compounds (2020-08-25),

11. 10717704 - Inhibitors of creatine transport and uses thereof (2020-07-21),

12. 10669296 - LXR agonists and uses thereof (2020-06-02),

13. 10512623 - Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof (2019-12-24),

14. 10377715 - 18-20 member bi-polycyclic compounds (2019-08-13),

15. 10308597 - Inhibitors of creatine transport and uses thereof (2019-06-04),

Title: Unveiling the Inventive Journey of Eduardo J Martinez

Introduction:

Eduardo J Martinez, hailing from Bryn Mawr, PA, is a prolific inventor who has made remarkable contributions to the field of pharmaceuticals and healthcare. With an impressive portfolio of 19 patents, Martinez stands as a beacon of innovation in the industry.

Latest Patents:

Martinez's recent patents include groundbreaking inventions such as 'Metal salts and uses thereof,' which focus on enhancing the physical properties and stability of certain metal salts for pharmaceutical compositions. Additionally, his invention 'Ascaroside derivatives and methods of use' showcases his commitment to developing novel treatments for immune disorders and inflammation.

Career Highlights:

Throughout his career, Martinez has left an indelible mark on the industry with his innovative solutions. He has notably worked with reputable companies such as Rgenix, Inc. and Inspirna, Inc., where he continued to push the boundaries of scientific exploration.

Collaborations:

In his quest for innovation, Martinez has collaborated with esteemed professionals in the field, including the likes of John Jeffrey Talley and Andreas G Grill. Together, they have synergized their expertise to spearhead cutting-edge research initiatives and pave the way for transformative advancements in healthcare.

Conclusion:

Eduardo J Martinez's inventive prowess and unwavering dedication to scientific discovery have positioned him as a trailblazer in the realm of pharmaceutical innovation. His groundbreaking patents and collaborative efforts underscore his profound impact on the industry, making him a driving force behind the evolution of modern healthcare practices.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…